Insights into Novel Drug Targets in Mycobacterium tuberculosis: Where Do We Stand and Where Do We Go from Here?

The key players in the arsenal of combating TB; reviewing the lead InhA inhibitors

1,8-Diaminonaphthalene-derived pharmacophore as potent anti-MRSA with dual DNA gyrase and topoisomerase IV inhibition

Geometrical and Topological Descriptors for Activities Modeling of some Potent Inhibitors against Mycobacterium Tuberculosis: A Genetic Functional Approach

DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY PROFILING STUDY OF IMIDAZOLINONE-BASED HYDRAZONES AS POTENTIAL MULTITARGET ANTIMYCOBACTERIAL AGENTS

Synthesis, In Vitro Biological Investigation, and In Silico Analysis of Pyrazole-Based Derivatives as Multi-target Agents

Discovery of Novel N-Acetylpyrazolines as Microtubule Inhibitors: Design, Synthesis, Anticancer Evaluation, and Molecular Docking Study

Synthesis of Novel Bivalent Hydrazino-Thymohydroquinone Analogs Derived from Thymoquinone as Potential Antimicrobial Agents

Imidazo[4,5-b]phenazines as Dual Topoisomerase I/IIα Inhibitors: Design, Synthesis, Biological Evaluation and Molecular Docking

Design, Synthesis and Antibacterial Study of New Agents Having 4-Thiazolidinone Pharmacophore